Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis

M Sherman - Seminars in liver disease, 2010 - thieme-connect.com
Hepatocellular carcinoma (HCC) is increasing in incidence in many countries, and is the
most common cause of death in patients with cirrhosis. With regular surveillance, small early …

AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC

K Yamamoto, H Imamura, Y Matsuyama… - Journal of …, 2010 - Springer
Abstract Background Alpha-fetoprotein (AFP), lens culinaris agglutinin-reactive fraction of
AFP (AFP-L3), des-γ-carboxy prothrombin (DCP), and Golgi protein-73 (GP73) have been …

Prognostic and diagnostic value of des-γ-carboxy prothrombin in liver cancer.

G Bertino, AM Ardiri, GS Calvagno… - Drug news & …, 2010 - europepmc.org
Des-γ-carboxy prothrombin (DCP) is an abnormal prothrombin induced by the absence of
vitamin K₂ that is increased in the serum of patients with hepatocellular carcinoma (HCC) …

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers

CM Sturgeon, MJ Duffy, BR Hofmann… - Clinical …, 2010 - academic.oup.com
Abstract Background: Updated National Academy of Clinical Biochemistry Laboratory
Medicine Practice Guidelines for the use of tumor markers in the clinic have been …

[HTML][HTML] 甲胎蛋白及其临床应用研究进展

常彬霞, 辛绍杰 - 世界华人消化杂志, 2010 - wjgnet.com
多年来甲胎蛋白在胎儿缺陷和肿瘤, 尤其是肝脏肿瘤的临床诊断中发挥着重要作用,
但其对于肝脏肿瘤的诊断缺乏特异性. 近年来随着对其作用机制和功能的深入研究 …

[HTML][HTML] GP73 与肝脏疾病关系的研究进展

李淑群, 陈谦 - 世界华人消化杂志, 2010 - wjgnet.com
Abstract GP73 (Golgi protein-73) 是最近发现的一种高尔基体膜蛋白, 在正常人体多种组织中
表达. 在正常肝脏中胆管上皮细胞呈高表达, 而肝细胞中几乎不表达, 但在多种肝脏疾病尤其是肝 …

[HTML][HTML] Proteomic analysis for developing new biomarkers of hepatocellular carcinoma

M Pleguezuelo, LM Lopez-Sanchez… - World Journal of …, 2010 - ncbi.nlm.nih.gov
METHODS: Patients with liver cirrhosis of the three most frequent etiologies: hepatitis C
virus, hepatitis B virus and alcoholic liver disease, were included in the study. The samples …

Current treatment strategies for hepatocellular carcinoma

A Aronsohn, SR Mohanty - Current Cancer Therapy Reviews, 2010 - ingentaconnect.com
Hepatocellular carcinoma (HCC) is a leading cause of cancer related death both in the
United States and worldwide. Proper management begins with identification of high risk …

[PDF][PDF] Proteomic analysis for developing new biomarkers of hepatocellular carcinoma

M Mata, M Pleguezuelo, R Ciria… - World Journal of …, 2010 - idus.us.es
AIM: To identify new markers of hepatocellular carcinoma (HCC) using a proteomic analysis.
METHODS: Patients with liver cirrhosis of the three most frequent etiologies: hepatitis C …

[引用][C] AFP-L3 含量测定在肝癌诊治中的意义

韩风, 邱大鹏, 陈伟瑜, 张玲, 韩有志 - 山东医药, 2010